Newron Pharmaceuticals S.p.A. (SWX: NWRN)
8.57
+0.08 (0.94%)
Sep 4, 2024, 4:36 PM CET
Newron Pharmaceuticals Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 2.81 | 2.81 | 1.36 | 2.87 | 1.77 | 1.53 | Upgrade
|
Cash & Short-Term Investments | 2.81 | 2.81 | 1.36 | 2.87 | 1.77 | 1.53 | Upgrade
|
Cash Growth | 106.24% | 106.24% | -52.54% | 61.96% | 15.89% | -81.88% | Upgrade
|
Accounts Receivable | 8.31 | 8.31 | 7.17 | 4.86 | 8.58 | 8.32 | Upgrade
|
Other Receivables | 1.46 | 1.46 | 2.46 | 2.05 | 1.86 | 2.74 | Upgrade
|
Receivables | 10.14 | 10.14 | 10.03 | 7.32 | 11.55 | 12.11 | Upgrade
|
Inventory | 21.37 | 21.37 | 13.59 | 18.87 | 14.27 | 19.76 | Upgrade
|
Other Current Assets | 7.95 | 7.95 | 6.23 | 2.88 | 3.91 | 6.97 | Upgrade
|
Total Current Assets | 42.27 | 42.27 | 31.21 | 31.95 | 31.5 | 40.37 | Upgrade
|
Property, Plant & Equipment | 47.44 | 47.44 | 41.63 | 45.84 | 25.36 | 20.48 | Upgrade
|
Long-Term Investments | - | - | - | - | 3.64 | 2.67 | Upgrade
|
Other Intangible Assets | 12.87 | 12.87 | 9.66 | 6.29 | 5.38 | 5.03 | Upgrade
|
Long-Term Accounts Receivable | - | - | - | - | 1.73 | 0.27 | Upgrade
|
Other Long-Term Assets | 1.82 | 1.82 | 6.18 | 3.25 | 4.03 | 4.27 | Upgrade
|
Total Assets | 106.05 | 106.05 | 90.82 | 89.68 | 73.23 | 73.09 | Upgrade
|
Accounts Payable | 12.6 | 12.6 | 10.84 | 12.08 | 10.56 | 8.2 | Upgrade
|
Accrued Expenses | 14.71 | 14.71 | 14.61 | 16.65 | 12.81 | 16 | Upgrade
|
Current Portion of Long-Term Debt | 2.32 | 2.32 | 18.87 | 13.99 | 30.34 | 17.47 | Upgrade
|
Current Portion of Leases | 2.67 | 2.67 | 2.74 | 3 | 1.95 | 1.87 | Upgrade
|
Current Unearned Revenue | 8.12 | 8.12 | 7.42 | 6.79 | 9.48 | 1.6 | Upgrade
|
Other Current Liabilities | 30.03 | 30.03 | 18.12 | 7.05 | 7.71 | 5.89 | Upgrade
|
Total Current Liabilities | 70.45 | 70.45 | 72.6 | 59.55 | 72.85 | 51.03 | Upgrade
|
Long-Term Debt | 68.83 | 68.83 | 52.66 | 34.21 | 9.06 | 20.74 | Upgrade
|
Long-Term Leases | 18.78 | 18.78 | 19.65 | 21.89 | 5.84 | 3.16 | Upgrade
|
Long-Term Deferred Tax Liabilities | - | - | - | - | - | 0.39 | Upgrade
|
Other Long-Term Liabilities | 0 | 0 | 0 | - | 0.82 | -0 | Upgrade
|
Total Liabilities | 160.81 | 160.81 | 144.91 | 115.65 | 94.75 | 85.82 | Upgrade
|
Common Stock | 58.61 | 58.61 | 44.48 | 33.52 | 26.01 | 15.38 | Upgrade
|
Additional Paid-In Capital | 0.29 | 0.29 | 30.67 | 56 | 55.46 | 16.59 | Upgrade
|
Retained Earnings | -112.74 | -112.74 | -132.37 | -112.82 | -93.88 | -31.4 | Upgrade
|
Comprensive Income & Other | -3.58 | -3.58 | 3.13 | -2.67 | -9.1 | -13.3 | Upgrade
|
Total Common Equity | -57.41 | -57.41 | -54.08 | -25.97 | -21.52 | -12.73 | Upgrade
|
Minority Interest | 2.66 | 2.66 | - | - | - | - | Upgrade
|
Shareholders' Equity | -54.75 | -54.75 | -54.08 | -25.97 | -21.52 | -12.73 | Upgrade
|
Total Liabilities & Equity | 106.05 | 106.05 | 90.82 | 89.68 | 73.23 | 73.09 | Upgrade
|
Total Debt | 92.6 | 92.6 | 93.91 | 73.09 | 47.19 | 43.25 | Upgrade
|
Net Cash (Debt) | -89.8 | -89.8 | -92.55 | -70.22 | -45.42 | -41.72 | Upgrade
|
Net Cash Per Share | -0.17 | -0.17 | -0.26 | -0.23 | -0.24 | -0.31 | Upgrade
|
Filing Date Shares Outstanding | 586.11 | 586.11 | 444.81 | 335.2 | 260.07 | 153.82 | Upgrade
|
Total Common Shares Outstanding | 586.11 | 586.11 | 444.81 | 335.2 | 260.07 | 153.82 | Upgrade
|
Working Capital | -28.18 | -28.18 | -41.39 | -27.6 | -41.35 | -10.66 | Upgrade
|
Book Value Per Share | -0.10 | -0.10 | -0.12 | -0.08 | -0.08 | -0.08 | Upgrade
|
Tangible Book Value | -70.28 | -70.28 | -63.74 | -32.26 | -26.9 | -17.76 | Upgrade
|
Tangible Book Value Per Share | -0.12 | -0.12 | -0.14 | -0.10 | -0.10 | -0.12 | Upgrade
|
Machinery | 44.15 | 44.15 | 46.13 | 47.16 | 38.04 | 35.72 | Upgrade
|
Construction In Progress | 11.24 | 11.24 | 1.11 | 1.54 | 5.58 | 2.73 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.